SEARCH

SEARCH BY CITATION

References

  • 1
    Centers for Disease Control and Prevention. Prevention and control of influenza: part I, vaccines. MMWR Morb Mortal Wkly Rep 1994; 43 (RR-9): 113.
  • 2
    Aschan J, Ringden O, Lujungman P, Anderson J, Lewensohn-Fuchs I, Forsgren M. Influenza B in transplant recipients. Scand J Infect Dis 1989; 21: 349350.
  • 3
    Ljungman P, Andersson J, Aschan J et al. Influenza A in immunocompromised patients. Clin Infect Dis 1993; 17: 244247.
  • 4
    Mauch TJ, Bratton S, Myers T, Krane E, Gentry SR, Kashtan CE. Influenza B virus infection in pediatric solid organ transplant recipients. Pediatrics 1994; 94: 225229.
  • 5
    Vilchez RA, Fung JJ, Kusne S. Influenza A myocarditis developing in an adult liver transplant recipient despite vaccination: a case report and review of the literature. Transplantation 2000; 70: 543545.
  • 6
    Garantziotis S, Howell DN, McAdams HP, Davis D, Henshaw NG, Palmer SM. Influenza pneumonia and association of bronchiolitis obliterans syndrome. Chest 2001; 119: 12771280.
  • 7
    Ljungman P, Gleaves CA, Meyers JD. Respiratory virus infection in immunocompromised patients. Bone Marrow Transplant 1989; 4: 3540.
  • 8
    Wenzel RP, Hendley JO, Sande MA et al. Revised (1972–73) bivalent influenza vaccine. Serum and nasal antibody responses to parental vaccination. JAMA 1973; 226: 435.
  • 9
    Kilbourne ED, Buttler WT, Rossen RC. Specific immunity in influenza: summary of influenza workshop III. J Infect Dis 1973; 127: 220.
  • 10
    Betts RF, O'Brien DM, Menegus M et al. A comparison of the protective benefits of influenza vaccine in reducing hospitalization of patients infected with influenza A and B [Abstract]. Clin Infect Dis 1993; 17: 573.
  • 11
    Blumberg EA, Albano C, Pruett T et al. The immunogenicity of influenza virus vaccine in solid organ transplant recipients. Clin Infect Dis 1996; 22: 295302.
  • 12
    Fraud S, Wagner D, Pethig K, Drescher J, Girgsdies OE, Haverich A. Influenza vaccine in heart transplant recipients. J Heart Lung Transplant 1999; 18: 220225.
  • 13
    Kumar SS, Ventura AK, Vander Werf B. Influenza vaccination in renal transplant recipients. JAMA 1978; 239: 840842.
  • 14
    Versiuis DJ, Beyer WEP, Masurel N, Wenting GJ, Weimar W. Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine but not azathioprine. Transplantation 1986; 42: 376379.
  • 15
    Mann JJ, Walderman RH, Togo Y et al. Antibody response in respiratory secretions of volunteers given live and dead influenza virus. J Immunol 1968; 100: 725.
  • 16
    Ponegar KB, Small PA, Jr. Immunoglobulin A: mediation of murine nasal anti-influenza virus immunity. J Virol 1991; 65: 21462148.
  • 17
    Couch RB, Douglas RG Jr, Rossen R et al. Role of secretory antibody in influenza. In: Dayton DH, Jr, Small PA Jr, Chanock RM et al., eds. The Secretory Immunologic System. Washington DC.: US GPO; 1969 93.
  • 18
    Briggs JD, Timbury MC, Paton AM, Bell PR. Viral infection and renal transplant rejection. Br Med J 1972; 4: 520522.
  • 19
    Keane WR, Heidemann JH, Luby J, Gailiunas P, Hull AR, Kokko JP. Epidemic renal transplant rejection associated with influenza A/Victoria. Kidney Int 1978; 14: 793.
  • 20
    Skoner DP, Gentile DA, Patel A, Doyle WJ. Evidence of cytokine mediation of disease expression in adults experimentally infected with influenza A. J Infect Dis 1999; 180: 1014.
  • 21
    Stiver HG, Graves P, Eikhoff TC et al. Efficacy of Hong Kong vaccine in preventing England variant influenza A in 1972. N Engl J Med 1973; 289: 1267.
  • 22
    Ruben FL, Johnson F, Streiff EJ. Influenza in partially immunized aged population: effectiveness of killed Hong Kong vaccine against infection with the England strain. JAMA 1974; 230: 863.
  • 23
    Dolin R, Reichman RC, Madore HP et al. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med 1982; 307: 580.
  • 24
    Betts RF, Treatnor JJ, Graman PS et al. Antiviral agents to prevent or treat influenza in the elderly. J Respir Dis 1987; 8 (Suppl.): 56.
  • 25
    Brady MT, Sears SD, Pacini DL et al. Safety and prophylactic efficacy of low-dose rimantadine in adults during an influenza A epidemic. Antimicrob Agent Chemother 1990; 34: 16331636.
  • 26
    Kim CU, Lew W, Williams MA et al. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocylic sialic acid analogues with potent anti-influenza activity. J Am Chem Soc 1997; 119: 681690.
  • 27
    Munos FM, Galasso GJ, Gwaltney JM et al. Current research on influenza and other respiratory viruses: II International Symposium. Antiviral Res 2000; 46: 91124.
  • 28
    Heyden FG, Gubareva LV, Monto AS et al. Inhaled zanamivir for the prevention of influenza and families. N Engl J Med 2000; 343: 12821289.